Shanbo Zheng

4PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 17, 2024
Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.

Jie Wang, Bin Li, Yawei Zhang

|Mar 07, 2019
tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas.

Muyu Kuang, Difan Zheng, Xiaoting Tao

|Sep 20, 2018
Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients.

Yunjian Pan, Chongze Yuan, Chao Cheng

|Aug 29, 2018
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.

Shanbo Zheng, Xiaoyang Luo, Chuanpeng Dong

Pageof 1

Frequent Collaborators

3 joint publications

Haiquan Chen

3 joint publications

Yunjian Pan

1 joint publications

Muyu Kuang

1 joint publications

Jie Wang